comparison of glp-1 agonists for weight loss Changes in with RAs in head-to-head clinical studies. *p < GLP-1 Vs Tirzepatide: Powerful Guide
Description
We used to think that the benefit of GLP-1 drugs (like Ozempic) was dependent on weight loss
Large-scale trials demonstrate average weight loss of 10-15% with semaglutide and 15-22% with tirzepatide, outcomes superior to older weight loss medications
This group of data suggests that BBR may preserve GLP-1 expression through an impact on L-cells in the colon
Novo is also facing legal flak from investors
White WB, Bakris GL, Bergenstal RM, Cannon CP, Cushman WC, Fleck P, Heller S, Mehta C, Nissen SE, Perez A, Wilson C, Zannad F
Probiotics are typically safe but are not appropriate for some immunocompromised people
